As global markets face ongoing volatility and geopolitical uncertainties, the Asian market continues to showcase a complex landscape of economic growth and challenges. In this environment, identifying high-growth companies with substantial insider ownership can be particularly compelling, as such ownership often signals confidence in the company's future prospects.
Top 10 Growth Companies With High Insider Ownership In Asia
| Name |
Insider Ownership |
Earnings Growth |
|---|---|---|
| UTI (KOSDAQ:A179900) |
24.7% |
120.7% |
| Streamax Technology (SZSE:002970) |
32.5% |
31.5% |
| Seers Technology (KOSDAQ:A458870) |
32% |
78.8% |
| Phison Electronics (TPEX:8299) |
10.8% |
31.7% |
| Novoray (SHSE:688300) |
23.6% |
31.4% |
| Loadstar Capital K.K (TSE:3482) |
31% |
23.6% |
| Laopu Gold (SEHK:6181) |
34.8% |
34.4% |
| Gold Circuit Electronics (TWSE:2368) |
31.4% |
37.5% |
| FUNDINNOInc (TSE:462A) |
33.4% |
41.5% |
| Fulin Precision (SZSE:300432) |
10.6% |
63.7% |
We're going to check out a few of the best picks from our screener tool.
HANA Micron
Simply Wall St Growth Rating:★★★★★☆
Overview:HANA Micron Inc. offers semiconductor back-end process packaging solutions in South Korea and has a market cap of approximately ₩2 trillion.
Operations:The company's revenue is primarily derived from Semiconductor Manufacturing at ₩2.24 billion and Semiconductor Material at ₩260.80 million, with additional income from New Technology Business financing amounting to ₩972.14 million.
Insider Ownership:18.3%
Revenue Growth Forecast:17.6% p.a.
HANA Micron's recent earnings report highlighted a significant turnaround, with net income of KRW 15.71 billion for Q3 2025 compared to a loss last year. Despite high share price volatility and interest payments not fully covered by earnings, the company is expected to see substantial annual profit growth of 88.1%, outpacing the Korean market average. Revenue growth is also projected at 17.6% annually, reflecting strong potential despite some financial challenges and large one-off items affecting results.
-
Click to explore a detailed breakdown of our findings in HANA Micron's earnings growth report.
-
The valuation report we've compiled suggests that HANA Micron's current price could be inflated.
Biocytogen Pharmaceuticals (Beijing)
Simply Wall St Growth Rating:★★★★★☆
Overview:Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a biotechnology company focused on the research and development of novel antibody-based drugs and pre-clinical research services across China, the United States, and internationally, with a market cap of HK$31.47 billion.
Operations:Biocytogen Pharmaceuticals generates revenue through several segments, including CN¥362.46 million from antibody development, CN¥497.82 million from animal model sales, CN¥66.09 million from gene editing, and CN¥274.47 million from pre-clinical pharmacology and efficacy evaluation services.
Insider Ownership:14.1%
Revenue Growth Forecast:17.1% p.a.
Biocytogen Pharmaceuticals (Beijing) demonstrates strong growth potential with earnings forecasted to grow significantly at 55.83% annually, outpacing the Hong Kong market. Despite recent insider selling and high share price volatility, the company remains undervalued by 62.4% compared to its fair value estimate. Revenue is expected to rise by 17.1% per year, supported by strategic partnerships like the recent agreement with Acepodia for bispecific antibody-drug conjugates development and a new IND clearance for IDE034 in collaboration with IDEAYA Biosciences.
Shenzhen Fastprint Circuit TechLtd
Simply Wall St Growth Rating:★★★★☆☆
Overview:Shenzhen Fastprint Circuit Tech Co., Ltd. designs, produces, and sells printed circuit boards both in China and internationally, with a market cap of CN¥42.13 billion.
Operations:Shenzhen Fastprint Circuit Tech Co., Ltd. generates its revenue by designing, producing, and selling printed circuit boards domestically and abroad.
Insider Ownership:25%
Revenue Growth Forecast:19.2% p.a.
Shenzhen Fastprint Circuit Tech Ltd. shows promising growth, with revenue for the nine months ending September 2025 rising to CNY 5.37 billion from CNY 4.35 billion a year ago, and net income reaching CNY 131.49 million from a previous loss. Earnings are expected to grow at an impressive rate of 94.77% annually, surpassing market averages, though future return on equity remains modest at 9.9%. Upcoming shareholder meeting may impact governance structure through director elections.
Summing It All Up
-
Access the full spectrum of 599 Fast Growing Asian Companies With High Insider Ownership by clicking on this link.
-
Interested In Other Possibilities? Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include KOSDAQ:A067310 SEHK:2315 and SZSE:002436.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
